tiprankstipranks
Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX
US Market

Amneal Pharmaceuticals (AMRX) Income Statement

Compare
514 Followers

Amneal Pharmaceuticals Income Statement

Last quarter (Q3 2024), Amneal Pharmaceuticals's total revenue was $702.47M, an increase of 13.29% from the same quarter last year. In Q3, Amneal Pharmaceuticals's net income was $-156.00K. See Amneal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.39B$ 2.21B$ 2.09B$ 1.99B$ 1.63B
Gross Profit
$ 820.57M$ 784.71M$ 768.97M$ 628.39M$ 353.00M
Operating Expenses
$ 616.19M$ 595.79M$ 575.07M$ 517.31M$ 491.88M
Depreciation and Amortization
$ 229.40M$ 240.18M$ 233.41M$ 235.39M$ 207.24M
EBITDA
$ 399.76M$ 150.43M$ 450.00M$ 381.05M$ 155.20M
Operating Income
$ 204.37M$ 206.46M$ 209.24M$ 91.16M$ -137.42M
Other Income/Expenses
$ -244.64M$ -153.20M$ -121.35M$ -126.94M$ 28.44M
Pretax Income
$ -40.27M$ -248.13M$ 31.37M$ -35.78M$ -220.24M
Net Income
$ -83.99M$ -254.79M$ 20.17M$ 68.58M$ -603.57M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.48$ -1.69$ 0.14$ 0.47$ -4.57
Diluted EPS
$ -0.48$ -1.69$ 0.13$ 0.46$ -4.57
Weighted Average Shares Outstanding
174.99M 150.94M 148.92M 147.44M 132.09M
Weighted Average Shares Outstanding (Diluted)
176.14M 150.94M 151.82M 148.91M 132.11M
Currency in USD

Amneal Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis